Dyslipidemia clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
Sorry, in progress, not accepting new patients
Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants with established cardiovascular disease (CVD).
Irvine, California and other locations

Last updated: December 29, 2025